Market News / Story
Roche taps Chinese startup for drug discovery
Seeking Alpha ·
Seeking Alpha reports: Roche has teamed up with Chinese startup Defand Therapeutics to discover new medicines as part of a collaboration worth close to $1B, Stat News reported on Thursday, citing a source familiar with the matter. Defand Therapeutics disclosed the agreement on Thursday under which it will leverage its degrader screening platform to discover a new class of treatments called molecular glue degraders in the areas of oncology and immunology. As part of the deal, Roche will…